Safety and Plasma Concentrations of a Cyclin-Dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts
Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-018-0712-7
Full Text
Open PDFAbstract
Available in full text
Date
October 4, 2018
Authors
Publisher
Springer Science and Business Media LLC